These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 6137836

  • 1. Potentiation of apomorphine-induced stereotypies by naloxone and L-prolyl-L-leucyl-glycinamide.
    Quock RM, Lucas TS, Hartl TJ.
    Pharmacol Biochem Behav; 1983 Jul; 19(1):49-52. PubMed ID: 6137836
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Possible noradrenergic involvement in naloxone potentiation of apomorphine-induced stereotypic climbing in mice.
    Quock RM, Bloom AS, Sadowski JA.
    Pharmacol Biochem Behav; 1984 Nov; 21(5):733-6. PubMed ID: 6096896
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Narcotic antagonist potentiation of apomorphine drug effect: a stereospecific, centrally mediated drug action.
    Quock RM, Kouchich FJ, Fries DS.
    Prog Neuropsychopharmacol Biol Psychiatry; 1985 Nov; 9(3):239-43. PubMed ID: 4041065
    [Abstract] [Full Text] [Related]

  • 7. Naloxone potentiation of apomorphine-induced stereotypic climbing in mice and interaction with mu-, sigma- and kappa-opiate drugs.
    Quock RM.
    Life Sci; 1982 Dec 20; 31(25):2907-11. PubMed ID: 6298534
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of dopaminergic and cholinergic drugs. naloxone and l-prolyl-leucyl-glycinamide on LSD-induced catalepsy.
    Chiu S, Mishra RK.
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Aug 20; 313(1):45-50. PubMed ID: 6111027
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Potentiation of apomorphine-induced rotational behaviour by naloxone.
    Quock RM, Welsh TB.
    J Pharm Pharmacol; 1981 Feb 20; 33(2):111-3. PubMed ID: 6111591
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prolyl-leucyl-glycinamide (PLG): inhibition of offensive aggression in mice.
    Kavaliers M, Hirst M.
    Life Sci; 1986 Nov 10; 39(19):1729-35. PubMed ID: 2877382
    [Abstract] [Full Text] [Related]

  • 14. MIF-1 attenuates apomorphine stereotypies in adult rats after neonatal 6-hydroxydopamine.
    Kostrzewa RM, White TG, Zadina JE, Kastin AJ.
    Eur J Pharmacol; 1989 Apr 12; 163(1):33-42. PubMed ID: 2568266
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Modulation of dopamine receptor agonist-induced rotational behavior in 6-OHDA-lesioned rats by a peptidomimetic analogue of Pro-Leu-Gly-NH2 (PLG).
    Mishra RK, Marcotte ER, Chugh A, Barlas C, Whan D, Johnson RL.
    Peptides; 1997 Apr 12; 18(8):1209-15. PubMed ID: 9396063
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dose-dependent effects of prolyl-leucyl-glycinamide on morphine-induced analgesia, tolerance and dependence.
    Contreras PC, Takemori AE.
    Eur J Pharmacol; 1984 Jun 15; 102(1):13-22. PubMed ID: 6148243
    [Abstract] [Full Text] [Related]

  • 20. Central action of melanostatin (MIF-1) in mice.
    Brus R, Szkilnik R, Stanosek B, Makowska B, Piguła J.
    Acta Physiol Pol; 1984 Jun 15; 35(5-6):447-53. PubMed ID: 6152791
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.